Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. 2000

S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
St Anna Children's Hospital, the Children's Cancer Research Institute, Vienna, Austria.

The case of a 4-month-old girl with familial hemophagocytic lymphohistiocytosis is described. The patient underwent stem cell transplantation from her haploidentical mother 2 months after receiving a living-related liver transplant from the same donor for acute hepatic failure. Conditioning regimen consisted of 16 mg/kg busulfan, 200 mg/kg cyclophosphamide, 10 mg/kg thiothepa, and antithymocyte globulin. Myeloid engraftment occurred on day +10, but CD3(+) cells of recipient origin remained. To convert the T-cell chimerism, the patient received donor lymphocyte infusion on day +43, and subsequently the allelic pattern changed to complete donor genotype on day +57. Four months after stem cell transplantation the patient is disease free, with complete donor chimerism in bone marrow and stable hepatic graft function without any immunosuppressive therapy. (Blood. 2000;96:3997-3999)

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001521 Behavior Therapy The application of modern theories of learning and conditioning in the treatment of behavior disorders. Behavior Change Techniques,Behavior Modification,Behavior Treatment,Conditioning Therapy,Therapy, Behavior,Therapy, Conditioning,Behavior Change Technique,Behavior Modifications,Behavior Therapies,Conditioning Therapies,Modification, Behavior,Technique, Behavior Change,Treatment, Behavior
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor

Related Publications

S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
February 2017, Bone marrow transplantation,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
April 2017, Zhonghua nei ke za zhi,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
April 2019, Journal of pediatric hematology/oncology,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
October 2019, Transplantation,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
April 2020, Transplant infectious disease : an official journal of the Transplantation Society,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
August 2018, Leukemia & lymphoma,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
April 2009, Bone marrow transplantation,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
September 2011, International journal of hematology,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
January 2018, Leukemia & lymphoma,
S Matthes-Martin, and C Peters, and A Königsrainer, and G Fritsch, and T Lion, and A Heitger, and K Kapelari, and M Kronberger, and F Offner, and F Wrba, and R Margreiter, and H Gadner
August 2021, Journal of clinical immunology,
Copied contents to your clipboard!